ACRS

ACRS Operating Income Growth

41.14%TTM

Period ending:

ACRS TTM Operating Income YoY %%
ACRS TTM Operating Income YoY %106.30%-339.46%
2015-12-312026-06-30

Source: Financial Modeling Prep (FMP). Trailing twelve months (TTM). TTM flows use four complete reported quarters. Growth compares with the corresponding period one year earlier.

ACRS operating income growth history

Year-over-year operating income growth rate. The available trailing twelve months (ttm) series contains 43 observations from Dec 31, 2015 to Jun 30, 2026.

Aclaris Therapeutics Inc Operating Income Growth — Trailing twelve months (TTM)
Period endingOperating Income Growth
41.1387%
42.9538%
46.1886%
-231.1146%
-117.5348%
-63.3484%
-45.7841%
62.1674%
39.6442%
14.3707%
-8.3502%
-46.2793%
-34.4173%
-25.9223%
-0.146%
-4.0776%
-17.7565%
-25.2851%
-76.2315%
-46.4165%
-4.8378%
39.5208%
60.0825%
63.1579%
57.8333%
25.449%
5.8125%
-22.3366%
-48.9993%
-56.7884%
-86.9765%
-107.8522%
-111.4401%
-87.0239%
-49.1198%
-40.4053%
-21.8764%
-55.1079%
-134.9978%
-126.0356%
-296.32%
-227.2317%
-142.2009%

Compare operating income growth

All ACRS financial metrics · ACRS stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.